Table: begin end state 1 36 cytoplasmic 37 56 transmembrane 57 79 non-cytoplasmic 80 102 transmembrane 103 108 cytoplasmic 109 133 transmembrane 134 161 non-cytoplasmic 162 180 transmembrane 181 237 cytoplasmic 238 257 transmembrane 258 262 non-cytoplasmic 263 288 transmembrane 289 602 cytoplasmic
Input: >WP_013091122.1 NCBI__GCF_000092885.1:WP_013091122.1 MNDTAELANPQLAAAHADALRERADYRIVPAKNRARLAGTVAAVLLIGIVLESVLGNPRW GWNVFAEWFLSEPVLSGLGRTLLLTALGAAFGFALGVPIALARVSRSPLLAGCAWAFVWL FRSIPLIVLLLILNNLGYLYETVHLGLPFTSVVVLDVPTTELISPFLAAVLGLTLNHAAF SAEVIRGGIQSVDHGQLEAAAALGLPRERQARRIVLPQAMRAIVPTAFNDLIALAKGSSM VYVLAMPELFYTVQIIYRRNLEVIPLLMVATVWYLIILTVLSAIQVYVERHFSRGVKRSA VPSAFGALLKSMGIARGGDVAHVEPFGDAKDNARAGASASLDQRWADQRDGARITIQQVS KSFGTLKVLDNVSLTMRPGSVTVILGQSGSGKSTLLRTINHLERVDGGLIDIDGELIGYR RDGDTLYELKEKEVLRRRVEVGMVFQSFNLFPHLTVLENIIEAPVALGRLSRAEAESLAL SLLARVGLEAKAHAWPRQLSGGQQQRVAIARALALKPKVLLFDEPTSALDPELVNEVLDV IKALARSGTTMVIVTHEIGFAREVADTIVFMDRGRVIESGPPAQVLNEPRHARTREFLSR VL
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server